drug
as of 2026-07-01NMDAE
at a glance
small molecule
Pre-approval / investigational in the US
Developed by China Medical University Hospital
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
4
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
NCT07122895Phase 2Recruiting
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197Phase 2Recruiting
Monotherapy of an NMDA Enhancer for Schizophrenia
NCT04745143Phase 2Recruiting
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853Phase 2Recruiting
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication